A61K33/10

Controllable ion release calcium particles, method for producing same and use thereof

The present invention refers to a method for the synthesis of a biodegradable calcium release material that shows controlled ion release properties for tissue engineering, biomaterials containing the calcium particles as well as the calcium particles obtainable therefrom. By varying the treatment temperature of the described method, the calcium material shows different calcium release profiles. Contrary to a specific chemical composition such as CaCO.sub.3 which is associated to a specific calcium release profile, the present invention allows a manifold of compositions, with a manifold of calcium release profiles, all starting from a single specific chemical composition calcium precursor. Therefore, the invention also relates to the use of the controllable release, calcium material in tissue regeneration such as wound healing processes.

Controllable ion release calcium particles, method for producing same and use thereof

The present invention refers to a method for the synthesis of a biodegradable calcium release material that shows controlled ion release properties for tissue engineering, biomaterials containing the calcium particles as well as the calcium particles obtainable therefrom. By varying the treatment temperature of the described method, the calcium material shows different calcium release profiles. Contrary to a specific chemical composition such as CaCO.sub.3 which is associated to a specific calcium release profile, the present invention allows a manifold of compositions, with a manifold of calcium release profiles, all starting from a single specific chemical composition calcium precursor. Therefore, the invention also relates to the use of the controllable release, calcium material in tissue regeneration such as wound healing processes.

TERAHERTZ MATERIAL HAVING THERAPEUTIC AND HEALTH CARE EFFECTS, PREPARATION METHOD THEREFOR AND USE THEREOF
20220348473 · 2022-11-03 ·

The present invention discloses a terahertz material with therapeutic and health care effect and its preparation method and application, which includes the following raw materials in parts by weight: 15˜28 SiO.sub.2, 3˜8 Al.sub.2O.sub.3, 1˜3 selenium, 2˜5 germanium, 10˜15 Fe.sub.2O.sub.3, 35˜45 ochre, 20˜35 zinc oxide, 65˜80 CaCO.sub.3, 0.1˜0.5 rare earth palladium, 1˜10 SiO.sub.x, wherein the raw materials of components are mixed according to the above proportion, and crushing, heating to 600˜1200° C. in an oxygen free environment for 3˜8 hours, and then secondary crushing, having a fineness of 3000˜8000 mesh; and then, after crushing again and powdering processing, the fineness reaches more than 10000 mesh. After being enhanced treatment by the terahertz irradiation line, the terahertz materials with therapeutic and health care effects are obtained. They can be processed and manufactured into a variety of physiotherapy equipment, with fast action speed and stable effect on human body.

TERAHERTZ MATERIAL HAVING THERAPEUTIC AND HEALTH CARE EFFECTS, PREPARATION METHOD THEREFOR AND USE THEREOF
20220348473 · 2022-11-03 ·

The present invention discloses a terahertz material with therapeutic and health care effect and its preparation method and application, which includes the following raw materials in parts by weight: 15˜28 SiO.sub.2, 3˜8 Al.sub.2O.sub.3, 1˜3 selenium, 2˜5 germanium, 10˜15 Fe.sub.2O.sub.3, 35˜45 ochre, 20˜35 zinc oxide, 65˜80 CaCO.sub.3, 0.1˜0.5 rare earth palladium, 1˜10 SiO.sub.x, wherein the raw materials of components are mixed according to the above proportion, and crushing, heating to 600˜1200° C. in an oxygen free environment for 3˜8 hours, and then secondary crushing, having a fineness of 3000˜8000 mesh; and then, after crushing again and powdering processing, the fineness reaches more than 10000 mesh. After being enhanced treatment by the terahertz irradiation line, the terahertz materials with therapeutic and health care effects are obtained. They can be processed and manufactured into a variety of physiotherapy equipment, with fast action speed and stable effect on human body.

COMPOSITION FOR AMELIORATING PSORIASIS COMPRISING CIMICIFUGOLIDE A AS ACTIVE INGREDIENT

Disclosed is a composition for use in preventing, alleviating, or treating psoriasis containing cimicifugolide A as an active ingredient.

COMPOSITION FOR AMELIORATING PSORIASIS COMPRISING CIMICIFUGOLIDE A AS ACTIVE INGREDIENT

Disclosed is a composition for use in preventing, alleviating, or treating psoriasis containing cimicifugolide A as an active ingredient.

ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDER
20230081497 · 2023-03-16 ·

The present document describes an oral care composition comprising a cuttlefish bone powder, comprising particles having more than 95% (w/w) calcium carbonate content, a specific surface area of at least 5 m.sup.2/g, a mechanical hardness about 4.75 to 6.87 GPa, and at least 20% of said particles of the powder have a particle size of from about 50 microns to about 70 microns and a mean of about 60 microns, and a suitable carrier, and uses of the composition for oral hygiene.

ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDER
20230081497 · 2023-03-16 ·

The present document describes an oral care composition comprising a cuttlefish bone powder, comprising particles having more than 95% (w/w) calcium carbonate content, a specific surface area of at least 5 m.sup.2/g, a mechanical hardness about 4.75 to 6.87 GPa, and at least 20% of said particles of the powder have a particle size of from about 50 microns to about 70 microns and a mean of about 60 microns, and a suitable carrier, and uses of the composition for oral hygiene.

Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
11602542 · 2023-03-14 · ·

The present invention provides stabilized amorphous calcium carbonate (ACC) formulations, comprising ACC and a non-aqueous liquid carrier in which the ACC is dispersed. The present invention further provides cosmetic and pharmaceutical compositions comprising ACC.

Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
11602542 · 2023-03-14 · ·

The present invention provides stabilized amorphous calcium carbonate (ACC) formulations, comprising ACC and a non-aqueous liquid carrier in which the ACC is dispersed. The present invention further provides cosmetic and pharmaceutical compositions comprising ACC.